Innovassynth Technologies Announces Rights Issue of 1.74 Crore Shares at ₹40 Each

3 min read     Updated on 26 Apr 2026, 09:44 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Innovassynth Technologies (India) Limited has announced a rights issue of up to 1,74,11,380 fully paid-up equity shares at ₹40 per share, including a premium of ₹30 per share. The issue is being offered to eligible equity shareholders in the ratio of 3 rights equity shares for every 13 fully paid-up equity shares held as on the record date of April 29, 2026. The issue size aggregates up to ₹6,964.55 lakhs, assuming full subscription. The issue opens on May 8, 2026, and closes on May 18, 2026. The company has received in-principle approval from BSE for listing the rights equity shares.

powered bylight_fuzz_icon
38722485

*this image is generated using AI for illustrative purposes only.

Innovassynth Technologies (India) Limited has announced a rights issue of up to 1,74,11,380 fully paid-up equity shares of face value ₹10 each at a price of ₹40 per share, including a premium of ₹30 per share. The issue aggregates up to ₹6,964.55 lakhs, assuming full subscription. The rights issue is being offered to eligible equity shareholders in the ratio of 3 rights equity shares for every 13 fully paid-up equity shares held as on the record date of April 29, 2026.

The company, formerly known as Innovassynth Investments Limited, was incorporated on February 15, 2008. Following a scheme of merger by absorption approved by the National Company Law Tribunal, Mumbai Bench-1 in November 2025, Innovassynth Technologies (India) Limited was merged into the company, and the company was renamed accordingly effective December 31, 2025.

Issue Details

Particulars Details
Rights Equity Shares Offered Up to 1,74,11,380 fully paid-up equity shares of ₹10 each
Rights Entitlement Ratio 3 rights equity shares for every 13 equity shares held
Issue Price ₹40 per rights equity share (including premium of ₹30)
Issue Size Up to ₹6,964.55 lakhs
Record Date April 29, 2026
Issue Opening Date May 8, 2026
Issue Closing Date May 18, 2026

The issue price of ₹40 per rights equity share is four times the face value of the equity shares. The rights equity shares issued pursuant to this issue will rank pari passu in all respects with the existing equity shares of the company.

Issue Schedule

Event Date
Last Date for Credit of Rights Entitlements April 30, 2026
Issue Opening Date May 8, 2026
Last Date for On-Market Renunciation May 12, 2026
Date of Closure of Off-Market Transfer May 15, 2026
Issue Closing Date May 18, 2026
Finalisation of Basis of Allotment May 19, 2026
Date of Allotment May 19, 2026
Date of Credit of Rights Equity Shares May 20, 2026
Date of Listing May 21, 2026

The board of directors or the rights issue committee reserves the right to extend the issue period, not exceeding 30 days from the issue opening date. No withdrawal of applications will be permitted after the issue closing date.

Objects of the Issue

The net proceeds from the issue, estimated at ₹6,882.11 lakhs after deducting issue-related expenses of ₹82.44 lakhs, are proposed to be utilized for the following purposes:

Sr. No. Particulars Amount (₹ in Lakhs)
1 Pre-payment of Rupee Term Loan from ICICI Bank Limited 4,400
2 To augment working capital requirements 850
3 General Corporate Purposes 1,632.11
Total 6,882.11

The company intends to utilize ₹4,400 lakhs for the full prepayment of the rupee term loan availed from ICICI Bank Limited. The working capital augmentation of ₹850 lakhs will support the company's manufacturing and contract research activities. The amount allocated for general corporate purposes will not exceed 25% of the gross proceeds.

Key Appointments

MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited) has been appointed as the registrar to the issue. ICICI Bank Limited is acting as the banker to the issue. ACER Credit Rating Private Limited has been appointed as the monitoring agency to oversee the utilization of the gross proceeds.

The existing equity shares of the company are listed on BSE Limited. The company has received in-principle approval from BSE for listing the rights equity shares to be allotted pursuant to this issue. The designated stock exchange for the issue is BSE Limited.

Historical Stock Returns for Innovassynth Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+8.21%+9.13%+41.36%+1.10%+14.97%+1,274.13%

How will the debt reduction from ICICI Bank loan prepayment impact Innovassynth's ability to compete for larger contracts in the specialty chemicals and pharmaceutical intermediates market?

What specific expansion plans does Innovassynth have for its Life Sciences vertical, particularly in the growing oligonucleotides manufacturing sector?

Will the improved financial flexibility from reduced debt servicing costs enable Innovassynth to pursue strategic acquisitions or partnerships in the CRDMO space?

Innovassynth Technologies
View Company Insights
View All News
like20
dislike

Innovassynth Technologies Files Quarterly Compliance Certificate for Q4FY26

1 min read     Updated on 14 Apr 2026, 12:17 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Innovassynth Technologies (India) Limited filed its quarterly compliance certificate for Q4FY26 under SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by Registrar Satellite Corporate Services Private Limited, confirms proper handling of physical share certificates for dematerialization and compliance with stock exchange listing requirements for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
37651659

*this image is generated using AI for illustrative purposes only.

Innovassynth Technologies (India) Limited has filed its quarterly compliance certificate with BSE Limited for the quarter ended March 31, 2026, fulfilling its regulatory obligations under SEBI regulations.

Regulatory Compliance Submission

The company submitted the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as required by Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The submission was made on April 13, 2026, and signed by Company Secretary Sameer Pakhali.

Parameter: Details
Quarter Period: Ended March 31, 2026
Filing Date: April 13, 2026
Regulation: SEBI (Depositories and Participants) Regulations, 2018
Authorized Signatory: Sameer Pakhali, Company Secretary (ACS 55746)

Certificate Details from Registrar

Satellite Corporate Services Private Limited, serving as the company's Registrar and Transfer Agent, issued the compliance certificate on April 06, 2026. The certificate confirms proper handling of physical share certificates received for dematerialization of the company's equity shares.

The Registrar certified two key compliance points:

  • The securities comprised in the certificates have been listed on the Stock Exchanges
  • The certificates have been properly verified, mutilated, cancelled, and the depository name has been substituted in records as the registered owner

Company Information

Innovassynth technologies operates from its registered office at Old Mumbai-Pune Road, Khopoli, and maintains its corporate office at TCG International Biotech Park in Pune. The company, formerly known as Innovassynth Investments Limited, trades under scrip code 533315 on BSE.

Office Type: Location Details
Registered Office: Old Mumbai-Pune Road, Khopoli – 410 203
Corporate Office: TCG International Biotech Park, Hinjewadi Phase – II, Pune – 411 057
Phone (Registered): +91-2192-260100
Phone (Corporate): +91-20-61921000

This quarterly filing demonstrates the company's commitment to maintaining regulatory compliance and transparency in its share transfer and dematerialization processes.

Historical Stock Returns for Innovassynth Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+8.21%+9.13%+41.36%+1.10%+14.97%+1,274.13%

What operational developments or business expansions might Innovassynth Technologies announce in their upcoming quarterly results for Q4 FY2026?

How could the company's transition from Innovassynth Investments Limited impact its strategic direction in the biotechnology sector?

Will Innovassynth Technologies consider upgrading to higher stock exchange tiers or seek additional listings given their compliance track record?

Innovassynth Technologies
View Company Insights
View All News
like18
dislike

More News on Innovassynth Technologies

1 Year Returns:+14.97%